ArticleFrontiers in pharmacology2018
Corrigendum: (-)-Epigallocatechin-3-Gallate Ameliorates Atherosclerosis and Modulates Hepatic Lipid Metabolic Gene Expression in Apolipoprotein E Knockout Mice: Involvement of TTC39B.
Wei Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.